Source link : https://newshealth.biz/health-news/zongertinib-picks-up-first-line-metastatic-nsclc-indication/
The accelerated approval for patients with HER2 (ERBB2)-mutated disease follows an approval last August for use after prior systemic therapy. Medscape Medical News Source link : https://www.medscape.com/viewarticle/zongertinib-picks-first-line-metastatic-nsclc-indication-2026a100066z?src=rss Author : Publish date : 2026-02-27 10:13:00 Copyright for syndicated content belongs to the linked Source.
The post Zongertinib Picks Up First-Line Metastatic NSCLC Indication first appeared on News Health.
—-
Author : News Health
Publish date : 2026-02-27 10:13:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8